Pursuing claims-based data on what happens to patients taking their drugs, pharma companies have been striking pacts with payers and PBMs. Now, a heavyweight in the research field, IMS Health, has ...

BOSTON, May 1 (Reuters) - Shares of IMS Health Inc. rose 6.5 percent on Tuesday after a U.S. federal judge overturned a New Hampshire law that banned commercial use of data tracking physician ...

IMS Health’s IPO raised more than $1.3 billion Friday by selling 65 million shares for $20 apiece. Shares quickly rose to $23 during Friday’s trading. Like Castlight Health, whose $3 billion public ...